Literature DB >> 1915770

Analysis of the immune system with transgenic mice: B cell development and lymphokines.

A Iglesias1.   

Abstract

Over the last decade transgenic mice expressing genes relevant for the immune system have been generated. Transgenic expression of immunoglobulin heavy and/or light chain genes of different isotypes and different specificities have helped to better understand phenomena relevant to B cell development such as allelic exclusion of immunoglobulins and B cell tolerance. Transgenic mice expressing interleukin genes have also been used to study the ways of action of these important growth and differentiation factors in the context of the mouse immune system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915770     DOI: 10.1007/bf01929877

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  61 in total

Review 1.  The published data.

Authors:  U Storb
Journal:  Immunol Rev       Date:  1990-06       Impact factor: 12.988

2.  Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice.

Authors:  E Adams; A Basten; C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain.

Authors:  S Pillai; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

4.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

5.  A transgenic immunoglobulin mu gene prevents rearrangement of endogenous genes.

Authors:  D Weaver; F Costantini; T Imanishi-Kari; D Baltimore
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

6.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

7.  Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.

Authors:  J Durdik; R M Gerstein; S Rath; P F Robbins; A Nisonoff; E Selsing
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Molecular requirements for the mu-induced light chain gene rearrangement in pre-B cells.

Authors:  A Iglesias; M Kopf; G S Williams; B Bühler; G Köhler
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

9.  Interleukin 4 expressed in situ selectively alters thymocyte development.

Authors:  D B Lewis; C C Yu; K A Forbush; J Carpenter; T A Sato; A Grossman; D H Liggitt; R M Perlmutter
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  Inhibition of immunoglobulin gene rearrangement by the expression of a lambda 2 transgene.

Authors:  J Hagman; D Lo; L T Doglio; J Hackett; C M Rudin; D Haasch; R Brinster; U Storb
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.